Table 3.
Analysis of kinetic of composite indexes and ultrasonographic data during the spacing phase as potential predictable factors of relapse after biologic agent withdrawal
Population | All | Relapser | Non-relapser | P value |
Composite indexes | ||||
Delta DAS 28 ESR > 0, % | 77 | 82.4 | 66.7 | 0.18 |
Delta DAS 28 ESR, mean (SD) | 0.4 (0.56) | 0.56 (0.57) | 0.19 (0.49) | 0.07 |
Delta DAS 28 CRP > 0, % | 48 | 52.9 | 37.5 | 0.149 |
Delta DAS 28 CRP, mean (SD) | 0.1 (0.62) | 0.22 (0.66) | −0.07 (0.5) | 0.582 |
Delta SDAI > 0, % | 60 | 70.6 | 37.5 | 0.03 |
Delta SDAI, mean (SD) | 0.8 (2.87) | 1.39 (3.17) | −0.34 (1.69) | 0.03 |
Ultrasonographic data | ||||
Delta GS score > 0, % | 17.4 | 12.5 | 28.6 | 0.55 |
Delta GS score, mean (SD) | 0 (0.98) | −0.19 (0.98) | 0.29 (0.95) | 0.39 |
Delta PD score > 0, % | 30.4 | 31.3 | 28.6 | 1 |
Delta PD score, mean (SD) | 0.1 (1.01) | 0.06 (1.06) | 0.29 (0.95) | 0.68 |
Delta global score > 0, % | 21.7 | 18.8 | 28.6 | 0.62 |
Delta global score, mean (SD) | −0.4 (5.01) | −1.06 (5.8) | 1.14 (1.95) | 0.16 |
CRP, C-reactive protein; DAS, Disease Activity Score; ESR, erythrocyte sedimentation rate; GS, grey scale; PD, power Doppler; SD, standard deviation; SDAI, Simplified Disease Activity Index.